-
Crackdown in Southeast Asia pushes scam networks to Sri Lanka
-
'Geek' hangout to tourist draw: Japan's maid cafes
-
Spacecraft to probe how Earth fends off raging solar winds
-
Bulgaria's 'Bangaranga' wins Eurovision, with Israel second
-
Musk wants SpaceX to go public. Here's how it works
-
Big risks and rewards in upcoming IPOs at SpaceX, OpenAI, Anthropic
-
Pal in last duo could ease nerves for PGA leader Smalley
-
Ronaldo suffers more agony as Al Nassr lose 1-0 in AFC final
-
Venezuela expels Maduro ally Alex Saab to US again
-
Rising star Woad in charge at LPGA Queen City Championship
-
Rodgers returning with Steelers for 22nd season
-
Rahm on PGA: 'It's a battle out there'
-
Dara: dancing to victory at Eurovision
-
Napoleon Solo wins 151st Preakness Stakes
-
Last 10 Eurovision winners
-
Smalley grabs PGA lead as wild final day showdown looms
-
Canada cruise passenger 'presumptive positive' for hantavirus
-
Five share PGA lead logjam with wild final day in store
-
Decision time at full-throttle Eurovision final
-
McIlroy charges into the hunt for epic major comeback win
-
Iran confirms squad heading to Turkey for World Cup preparation
-
Bolivian police clash with protesters blocking roads
-
Eurovision final kicks off with Viennese grandeur
-
Svitolina sees off Gauff to win Italian Open, Sinner in men's title showdown
-
Alonso set for appointment as Chelsea manager: reports
-
Spanish star Javier Bardem says 'narrative changing' on Gaza
-
Gujarat miss out on top spot as Kolkata stay alive in IPL
-
Charging McIlroy grabs share of the PGA lead
-
Rwanda genocide suspect Kabuga dead: court
-
No beer for City stars despite FA Cup win, says Guardiola
-
Modi oversees semi-conductor deal on Dutch trip
-
Americans 'should demonstrate like the French,' says Woody Harrelson
-
Vienna abuzz for Eurovision final
-
McFarlane eyes 'massive' Spurs clash after FA Cup final defeat
-
Scuffles from Europe to NYC as Swatch sale descends into chaos
-
Bielle-Biarrey helps Bordeaux-Begles avoid Top 14 slip-up before Champions Cup final
-
Man City still dream of Premier League glory after FA Cup win: Silva
-
Hearts broken as O'Neill summons Celtic's champion spirit
-
'Dance all night': Harry Styles kicks off World Tour in Amsterdam
-
Kane hits hat-trick, St. Pauli relegated from Bundesliga
-
Semenyo's magic moment fires Man City to FA Cup final win over Chelsea
-
Football back on war-battered pitches in Sudan capital
-
Opposition Latvian lawmaker tapped to form interim government
-
Kane hits hat-trick, St. Pauli are relegated from Bundesliga
-
Modi oversees semiconductor deal on Dutch trip
-
UK's ex-health minister Streeting says will run to replace PM Keir Starmer
-
Israel could wean itself off US defence aid, but not yet
-
Narvaez racks up second stage win at Giro d'Italia
-
Kim, Rose and Kirk charge into PGA hunt as McIlroy starts his third round
-
Whale that was rescued after stranded in Germany found dead in Denmark
US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
O.Karlsson--AMWN